The European Advisory Board on Cat Diseases (ABCD) invites applications for the ABCD & Merial Young Scientist Award 2010.
Candidates should have made an original contribution to the field of feline infectious diseases and/or immunology, which has been published or accepted for publication in a referenced journal (PubMed, Web of Science, Web of Knowledge), or accepted by another assessing body (e.g. a Thesis Committee) in 2008 or later.
Candidates should be based in Europe (EU or EFTA country), have completed a veterinary or biomedical curriculum, and be 35 years of age or younger.
Applications should be made in English in an electronic format and include a short abstract (max. 500 words) of the work the applicant wishes to submit, as well as a short curriculum vitae and two personal references. Any relevant publications and/or dissertation on the topic should be included.
The deadline for submission is 1 February 2010.
The award of 1000 € is funded by Merial and will be presented by the ABCD at the congress of the European Society of Feline Medicine (ESFM) to be held in Amsterdam (Netherlands) from 18 to 20 June 2010. The award winner will be informed and receive a complimentary registration to this congress. Return travel expenses and accommodation will also be covered to allow the laureate to attend the event. The award will be given at the winner’s presentation of his/her findings at this event.
Recipient of the ABCD & Merial Young Scientist Award 2009, presented at the ESFM congress on 20 June in Dubrovnik, was Dr Jonas Wensman (SLU, Sweden), for his work on borna disease in cats.
Notes to Editors:
The European Advisory Board on Cat Diseases (ABCD) is an independent panel of 17 leading veterinarians from ten European countries, with an expertise in immunology, vaccinology and/or feline medicine. The ABCD was set up to compile guidelines for the prevention and management of major feline infectious diseases in Europe, based on current scientific knowledge. For more information, please visit www.abcd-vets.org.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.
Merial employs approximately 5,700 people and operates in more than 150 countries worldwide. Its 2008 sales were over $2.6 billion. Merial is the Animal Health subsidiary of sanofi-aventis. For more information, please see www.merial.com.